Skip to main content
. Author manuscript; available in PMC: 2012 Nov 25.
Published in final edited form as: J Mol Cell Cardiol. 2005 Oct 19;39(6):865–873. doi: 10.1016/j.yjmcc.2005.09.007

Fig. 3.

Fig. 3

Signaling pathway inhibition of human ES cell-derived cardiomyocyte proliferation. H7 human ES cells were differentiated for 19 days before Percoll separation, and fraction IV cells were cultured for an additional 4 days in serum-free media with various signaling inhibitors. The inhibitors were added for the final 48 hours of culture prior to fixation. Only the PI 3-kinase inhibitor (LY294002) significantly inhibited human ES cell-derived cardiomyocyte proliferation (* = P < 0.05).

HHS Vulnerability Disclosure